Related references
Note: Only part of the references are listed.Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions
Marc Arbyn et al.
ANNALS OF INTERNAL MEDICINE (2017)
Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2
Mark Schiffman et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2017)
Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma
S. Nicolas-Parraga et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer
Megan A. Clarke et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
Nicolas Wentzensen et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Optimizing secondary prevention of cervical cancer: Recent advances and future challenges
Gina Ogilvie et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2017)
HPV prevalence in women attending cervical screening in rural Malawi using the cartridge-based Xpert® HPV assay
Heather A. Cubie et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
Kimberley Kavanagh et al.
LANCET INFECTIOUS DISEASES (2017)
Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference
Paolo Giorgi Rossi et al.
PREVENTIVE MEDICINE (2017)
Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings
Nicole G. Campos et al.
CANCER MEDICINE (2017)
Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry
Grazyna A. Stanczuk et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway
Sveinung Wergeland Sorbye et al.
BMC CLINICAL PATHOLOGY (2017)
HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis
Lisa Mirabello et al.
CELL (2017)
Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway
Emily A. Burger et al.
BRITISH JOURNAL OF CANCER (2017)
Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results
Sandra D. Isidean et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Use of Cytology, E6/E7 mRNA and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening
Daniela Gustinucci et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer
Nancy Santesso et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2016)
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
F. Xavier Bosch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer Prevention
Attila T. Lorincz
ACTA CYTOLOGICA (2016)
HPV immunisation and cervical screening-confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study
T. J. Palmer et al.
BRITISH JOURNAL OF CANCER (2016)
Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms
Guglielmo Ronco et al.
EUROPEAN JOURNAL OF CANCER (2016)
Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
Lise M. A. De Strooper et al.
GYNECOLOGIC ONCOLOGY (2016)
Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi
Christine Campbell et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Validation of a DNA methylation HPV triage classifier in a screening sample
Attila T. Lorincz et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Triage of HPV positive women in cervical cancer screening
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women
Lisa Mirabello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women
Lisa Mirabello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013
Ross L. Cameron et al.
EMERGING INFECTIOUS DISEASES (2016)
Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm
Cheng-Chang Chang et al.
BMC CANCER (2015)
Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results
Christine Bergeron et al.
CANCER CYTOPATHOLOGY (2015)
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
M. Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials
F. Verdoodt et al.
EUROPEAN JOURNAL OF CANCER (2015)
Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
Warner K. Huh et al.
GYNECOLOGIC ONCOLOGY (2015)
Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
Christine Bergeron et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
Nicolas Wentzensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Melanie Drolet et al.
LANCET INFECTIOUS DISEASES (2015)
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
Aimee R. Kreimer et al.
LANCET ONCOLOGY (2015)
Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial
Christine Bergeron et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
Nicolas Wentzensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results
M. Schiffman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection
Michael Cullen et al.
PAPILLOMAVIRUS RESEARCH (2015)
DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women
A. Boers et al.
BRITISH JOURNAL OF CANCER (2014)
Interobserver Reproducibility and Accuracy of p16/Ki-67 Dual-Stain Cytology in Cervical Cancer Screening
Nicolas Wentzensen et al.
CANCER CYTOPATHOLOGY (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Marc Arbyn et al.
LANCET ONCOLOGY (2014)
Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial
Viola M. J. Verhoef et al.
LANCET ONCOLOGY (2014)
Human Papillomavirus 16 Non-European Variants Are Preferentially Associated with High-Grade Cervical Lesions
Luciana Bueno Freitas et al.
PLOS ONE (2014)
Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia
Mina Kalantari et al.
VIROLOGY (2014)
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Renske D. M. Steenbergen et al.
NATURE REVIEWS CANCER (2014)
HPV16 genetic variation and the development of cervical cancer worldwide
I. Cornet et al.
BRITISH JOURNAL OF CANCER (2013)
High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening
Peter J. F. Snijders et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Benchmarking CIN 3+Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial
Francesca Carozzi et al.
LANCET ONCOLOGY (2013)
Association of human papillomavirus type 16 long control region mutation and cervical cancer
Chamsai Pientong et al.
VIROLOGY JOURNAL (2013)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
Debbie Saslow et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing
M. Hendry et al.
BRITISH JOURNAL OF CANCER (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
Marc Arbyn et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Methylation of Human Papillomavirus Type 16 Genome and Risk of Cervical Precancer in a Costa Rican Population
Lisa Mirabello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3
Nicolas Wentzensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
Risks for Persistence and Progression by Human Papillomavirus Type 16 Variant Lineages Among a Population-Based Sample of Danish Women
Tarik Gheit et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Combined Promoter Methylation Analysis of CADM1 and MAL: An Objective Triage Tool for High-Risk Human Papillomavirus DNA-Positive Women
Albertus T. Hesselink et al.
CLINICAL CANCER RESEARCH (2011)
Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study
J. J. H. Eijsink et al.
GYNECOLOGIC ONCOLOGY (2011)
Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
Aimee R. Kreimer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
A Population-Based Prospective Study of Carcinogenic Human Papillomavirus Variant Lineages, Viral Persistence, and Cervical Neoplasia
Mark Schiffman et al.
CANCER RESEARCH (2010)
HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix
Koen D. Quint et al.
GYNECOLOGIC ONCOLOGY (2010)
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis
I. Tsoumpou et al.
CANCER TREATMENT REVIEWS (2009)
Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science
Nicolas Wentzensen et al.
GYNECOLOGIC ONCOLOGY (2009)
Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population
Rosemary E. Zuna et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
Henry C. Kitchener et al.
LANCET ONCOLOGY (2009)
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Knowledge about infection with human papillomavirus: A systematic review
Stefanie J. Klug et al.
PREVENTIVE MEDICINE (2008)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18
Laura Sichero et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Risk for high-grade cervical Intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18
Long Fu Xi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Variants of human papillomavirus types 16 and 18: Histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in cervical smear
Silvia Helena Rabelo-Santos et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)
A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines
Michelle Giles et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2006)
High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush
Antoinette A. T. P. Brink et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
The epidemiology of genital human papillomavirus infection
H Trottier et al.
VACCINE (2006)
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
L Kotaniemi-Talonen et al.
BRITISH JOURNAL OF CANCER (2005)
P16INK4A positivity in benign, premalignant and malignant cervical glandular lesions:: a potential diagnostic problem
N Murphy et al.
VIRCHOWS ARCHIV (2004)
Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia
AJ Kruse et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections
MV Doeberitz
EUROPEAN JOURNAL OF CANCER (2002)
Asian-American variants of human papillomavirus 16 and risk for cervical cancer:: a case-control study
J Berumen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Human papillomavirus type 16 variants and risk of cervical cancer
A Hildesheim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
